The use of Ozempic for weight loss in non-diabetic individuals is still relatively new, and its essential to follow a healthcare professionals guidance to ensure safety and effectiveness in achieving weight management goals
However, the timeline for significant results varies depending on whether your goal is weight loss or blood sugar control, with full benefits developing over several months of consistent use
Patients should never discontinue semaglutide without medical guidance, as abrupt cessation may lead to worsening glycemic control or weight regain
If clinical suspicion exists based on history or examination findings, appropriate evaluationpotentially including thyroid ultrasound, serum calcitonin, or genetic testing for RET mutationsshould be completed before starting therapy
These findings suggest that once-weekly subcutaneous semaglutide, when combined with lifestyle interventions, offers superior weight loss benefits in individuals with overweight or obesity compared to once-daily subcutaneous liraglutide [10]
Every batch of injectable medication should undergo sterility testing before release